Supplier Viability and Compliance A suppliers stability is foundational to a reliable partnership
Cost Comparison: What Youll Actually Pay Heres what you can expect to pay monthly for different GLP-1 programs: Most Affordable Options (Under $300/month): TrimRx: $199-$349/month (compounded medications, no separate membership fee) Eden: $196-$296/month (brand-name medications, no separate membership fee) PlushCare: $19.99/month + copay + medication costs (best if you have good insurance) Mid-Range Options ($300-$600/month): Noom Med: $42.25/month membership + medication costs G-Plans: $99-$129/month + medication costs Form Health: $299/month + medication costs Hers/Hims: $299-$599/month (includes medication) Premium Options ($600+/month): Ro Body: $145/month + $900-$1,000/month for medication Most brand-name GLP-1 programs without insurance: $900-$1,350/month Hidden Costs to Watch For: Initial consultation fees ($39-$129 at some providers) Monthly membership fees separate from medication costs Blood work requirements (may cost $75-$200 if not covered) Cancellation fees (Found charges $129 if you cancel before six months) Shipping fees (most providers offer free shipping) Money-Saving Strategies: Choose compounded medications: Save $500-$800 per month compared to brand-name options Commit to longer plans: Most providers offer discounts for quarterly or annual commitments Use HSA/FSA funds: Several programs are HSA/FSA eligible even if they dont accept insurance Check insurance coverage: Even if the program doesnt accept insurance, your insurance might cover the medication at a local pharmacy Safety Considerations and Accreditation What to Look for in a Safe GLP-1 Provider: Licensed Healthcare Providers All legitimate telehealth GLP-1 programs must have licensed physicians, nurse practitioners, or physician assistants who are authorized to prescribe in your state
10.1152/physrev.00044.2003
Although these techniques have proven helpful in the field, they can also come with drawbacks, including expense, laboriousness, and the requirement for professional experts and supplies, especially in less spacious or poorly equipped laboratories (Raja, 2020)
So I don't want people to despair that if they can't access the GLP-1s via the Medicaid Part D program or another program, there are other ways to receive data-driven obesity treatment
